Investigative Site Landscape Remains Highly Fragmented as the Number of Active Investigators Worldwide Reaches an All-Time High, According to the Tufts Center for the Study of Drug Development
3/12/2013 9:10:48 AM
More...
|
Companion Diagnostics, Key to Development of Personalized Medicines, Face Hurdles, According to Tufts Center for the Study of Drug Development
1/24/2013 8:40:52 AM
More...
|
New Research From Tufts Center for the Study of Drug Development Characterizes Effectiveness and Variability of Patient Recruitment and Retention Practices
1/15/2013 9:09:15 AM
More...
|
Extraneous Data Collected in Clinical Trials Cost Drug Developers $4 Billion to $6 Billion Annually, According to Tufts Center for the Study of Drug Development
11/6/2012 7:27:26 AM
More...
|
Contract Support and Technical Service Providers Expected to Play a Growing Role in Drug Development, According to Tufts Center for the Study of Drug Development
10/17/2012 8:58:34 AM
More...
|
U.S. Patients Get More Cancer Drugs Access, But Pay for Privilege, Tufts Center for the Study of Drug Development Study
7/11/2012 8:20:38 AM
More...
|
U.S. Cancer Patients Get Faster Access to More Oncology Drugs Than European Patients, According to Tufts Center for the Study of Drug Development
7/10/2012 8:22:03 AM
More...
|
Clinical Trials Can Waste How Much Money? Tufts Center for the Study of Drug Development Study
7/10/2012 8:13:28 AM
More...
|
Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, According to Tufts Center for the Study of Drug Development
5/9/2012 11:25:16 AM
More...
|
Drug Companies are Looking to Shorten Time to Early Clinical Development, According to Tufts Center for the Study of Drug Development
4/26/2012 9:35:54 AM
More...
|
|